

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Kapor Capital Opportunity Fund IFiled to raise in 2023, with no closing reported yet. | 2023 | $50M | $0 | 0 |
| Kapor Capital III | June 2021 | $125M | $98M | 57 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Uriridiakoghene Onovakpuri | Slowing | Digital health, Healthcare services | 4 |
Categories of Kapor Capital’s own portfolio companies, based on 7 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Flare Capital | 1 | OnCall Health |
| Walden Catalyst Ventures | 1 | Bloomlife |
A shared board seat: a company where filings name a Kapor Capital partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
| 1 |
| Brian Dixon | Quiet | Biotech & pharma, Consumer apps & internet, Education | 3 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Kapor Capital’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.